Phreesia, Inc. Share Price

Equities

PHR

US71944F1066

Software

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
20.61 USD +0.73% Intraday chart for Phreesia, Inc. -5.02% -10.97%
Sales 2025 * 428M 34.25B Sales 2026 * 507M 40.61B Capitalization 1.16B 93.03B
Net income 2025 * -92M -7.36B Net income 2026 * -69M -5.52B EV / Sales 2025 * 2.56 x
Net cash position 2025 * 65.84M 5.27B Net cash position 2026 * 80.06M 6.41B EV / Sales 2026 * 2.13 x
P/E ratio 2025 *
-12.4 x
P/E ratio 2026 *
-16.4 x
Employees 1,438
Yield 2025 *
-
Yield 2026 *
-
Free-Float 93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.73%
1 week-5.02%
Current month-13.87%
1 month-15.50%
3 months-18.38%
6 months+65.54%
Current year-10.97%
More quotes
1 week
20.27
Extreme 20.27
23.68
1 month
20.27
Extreme 20.27
24.04
Current year
20.27
Extreme 20.27
29.16
1 year
12.05
Extreme 12.05
34.98
3 years
12.05
Extreme 12.05
76.10
5 years
12.05
Extreme 12.05
81.59
10 years
12.05
Extreme 12.05
81.59
More quotes
Managers TitleAgeSince
Founder 45 31/12/04
Founder 45 31/12/04
Director of Finance/CFO 50 30/06/19
Members of the board TitleAgeSince
Director/Board Member 71 30/09/07
Director/Board Member 53 30/04/19
Director/Board Member 56 19/07/20
More insiders
Date Price Change Volume
26/04/24 20.61 +0.73% 502,316
25/04/24 20.46 -6.75% 599,307
24/04/24 21.94 -5.19% 523,436
23/04/24 23.14 +3.26% 386,053
22/04/24 22.41 +3.27% 298,650

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
20.61 USD
Average target price
30.12 USD
Spread / Average Target
+46.17%
Consensus